Raras
Buscar doenças, sintomas, genes...
Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA
ORPHA:90635CID-10 · H90.3CID-11 · AB50DOENÇA RARA

Forma autossômica dominante de surdez não sindrômica.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Forma autossômica dominante de surdez não sindrômica.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H90.3
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👂
Ouvidos
26 sintomas
🩸
Sangue
3 sintomas
👁️
Olhos
3 sintomas
🧠
Neurológico
3 sintomas
🫘
Rins
1 sintomas
🫃
Digestivo
1 sintomas

+ 16 sintomas em outras categorias

Características mais comuns

Deficiência auditiva neurossensorial progressiva
Trombocitopenia
Macrotrombocitopenia
Agregação plaquetária prejudicada
Hemorragia pós-parto
Partição incompleta da cóclea tipo II
53sintomas
Sem dados (53)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 53 características clínicas mais associadas, ordenadas por frequência.

Deficiência auditiva neurossensorial progressivaProgressive sensorineural hearing impairment
TrombocitopeniaThrombocytopenia
MacrotrombocitopeniaMacrothrombocytopenia
Agregação plaquetária prejudicadaImpaired platelet aggregation
Hemorragia pós-partoPost-partum hemorrhage

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

60 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

SLC17A8Vesicular glutamate transporter 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Multifunctional transporter that transports L-glutamate as well as multiple ions such as chloride, sodium and phosphate (PubMed:12151341, PubMed:33440152). At the synaptic vesicle membrane, mainly functions as an uniporter that mediates the uptake of L-glutamate into synaptic vesicles at presynaptic nerve terminals of excitatory neural cells (PubMed:12151341). The L-glutamate uniporter activity is electrogenic and is driven by the proton electrochemical gradient, mainly by the electrical gradien

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membraneCell membraneSynapse, synaptosome

VIAS BIOLÓGICAS (1)
SLC-mediated transport of neurotransmitters
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 25

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA25 expression is variable in terms of onset and rate of progression, with an age-dependent penetrance resembling an early-onset presbycusis, or senile deafness, a progressive bilateral loss of hearing that occurs in the aged.

EXPRESSÃO TECIDUAL(Baixa expressão)
Intestino delgado
2.9 TPM
Hipotálamo
1.0 TPM
Brain Caudate basal ganglia
0.9 TPM
Cérebro - Amígdala
0.7 TPM
Hipocampo
0.6 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 25autosomal dominant nonsyndromic hearing loss
HGNC:20151UniProt:Q8NDX2
EPHA10Ephrin type-A receptor 10Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor for members of the ephrin-A family. Binds to EFNA3, EFNA4 and EFNA5

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (2)
EPH-ephrin mediated repulsion of cellsEPH-Ephrin signaling
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 88

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA88 is characterized by postlingual, progressive and severe hearing loss with tinnitus.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
33.1 TPM
Cólon transverso
14.7 TPM
Pituitária
11.3 TPM
Córtex cerebral
9.0 TPM
Brain Frontal Cortex BA9
7.7 TPM
OUTRAS DOENÇAS (1)
hearing loss, autosomal dominant 88
HGNC:HGNC:19987UniProt:Q5JZY3
SLC12A2Solute carrier family 12 member 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Cation-chloride cotransporter which mediates the electroneutral transport of chloride, potassium and/or sodium ions across the membrane (PubMed:16669787, PubMed:32081947, PubMed:32294086, PubMed:33597714, PubMed:35585053, PubMed:36239040, PubMed:36306358, PubMed:7629105). Plays a vital role in the regulation of ionic balance and cell volume (PubMed:16669787, PubMed:32081947, PubMed:32294086, PubMed:7629105)

LOCALIZAÇÃO

Basolateral cell membrane

VIAS BIOLÓGICAS (1)
Cation-coupled Chloride cotransporters
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 78

A form of non-syndromic deafness characterized by congenital, profound bilateral sensorineural hearing loss affecting all frequencies. Some patients may have mild motor delay early in life due to vestibular dysfunction. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
46.6 TPM
Glândula salivar
43.8 TPM
Brain Spinal cord cervical c-1
38.2 TPM
Intestino delgado
28.1 TPM
Esôfago - Muscular
27.6 TPM
OUTRAS DOENÇAS (3)
Kilquist syndromeDelpire-McNeill syndromehearing loss, autosomal dominant 78
HGNC:10911UniProt:P55011
DIAPH1Protein diaphanous homolog 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Actin nucleation and elongation factor required for the assembly of F-actin structures, such as actin cables and stress fibers (By similarity). Binds to the barbed end of the actin filament and slows down actin polymerization and depolymerization (By similarity). Required for cytokinesis, and transcriptional activation of the serum response factor (By similarity). DFR proteins couple Rho and Src tyrosine kinase during signaling and the regulation of actin dynamics (By similarity). Functions as a

LOCALIZAÇÃO

Cell membraneCell projection, ruffle membraneCytoplasm, cytoskeletonCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasmNucleus

VIAS BIOLÓGICAS (8)
ERBB2 Regulates Cell MotilityRHO GTPases Activate ForminsRegulation of MITF-M dependent genes involved in invasionRHOF GTPase cycleRHOD GTPase cycle
MECANISMO DE DOENÇA

Deafness, autosomal dominant 1, with or without thrombocytopenia

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. Patients may have mild thrombocytopenia and enlarged platelets, although most of DFNA1 affected individuals do not have significant bleeding tendencies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
99.8 TPM
Músculo esquelético
95.6 TPM
Pulmão
82.2 TPM
Esôfago - Mucosa
81.2 TPM
Skin Sun Exposed Lower leg
72.3 TPM
OUTRAS DOENÇAS (4)
progressive microcephaly-seizures-cortical blindness-developmental delay syndromeautosomal dominant nonsyndromic hearing loss 1Moyamoya diseaseDIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
HGNC:2876UniProt:O60610
ATOH1Transcription factor ATOH1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Transcriptional regulator. Activates E box-dependent transcription in collaboration with TCF3/E47, but the activity is completely antagonized by the negative regulator of neurogenesis HES1. Plays a role in the differentiation of subsets of neural cells by activating E box-dependent transcription (By similarity)

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 89

An autosomal dominant form of non-syndromic deafness characterized by progressive hearing loss, with onset at birth or early childhood.

OUTRAS DOENÇAS (1)
hearing loss, autosomal dominant 89
HGNC:HGNC:797UniProt:Q92858
PI4KBPhosphatidylinositol 4-kinase betaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Phosphorylates phosphatidylinositol (PI) in the first committed step in the production of the second messenger inositol-1,4,5,-trisphosphate (PIP). May regulate Golgi disintegration/reorganization during mitosis, possibly via its phosphorylation. Involved in Golgi-to-plasma membrane trafficking (By similarity) (PubMed:10559940, PubMed:11277933, PubMed:12749687, PubMed:9405935). May play an important role in the inner ear development (Microbial infection) Plays an essential role in Aichi virus RN

LOCALIZAÇÃO

Endomembrane systemMitochondrion outer membraneRough endoplasmic reticulum membraneGolgi apparatusGolgi apparatus membraneCytoplasm, perinuclear region

VIAS BIOLÓGICAS (1)
Synthesis of PIPs at the Golgi membrane
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 87

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA87 is characterized by prelingual, profound sensorineural hearing loss with inner ear anomalies, including cochlear maldevelopment, absence of the osseous spiral lamina, and/or an enlarged vestibular aqueduct.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
100.6 TPM
Útero
97.3 TPM
Tireoide
95.0 TPM
Fallopian Tube
88.0 TPM
Cervix Endocervix
86.3 TPM
OUTRAS DOENÇAS (1)
hearing loss, autosomal dominant 87
HGNC:HGNC:8984UniProt:Q9UBF8
LMX1ALIM homeobox transcription factor 1-alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a transcriptional activator by binding to an A/T-rich sequence, the FLAT element, in the insulin gene promoter. Required for development of the roof plate and, in turn, for specification of dorsal cell fates in the CNS and developing vertebrae (By similarity)

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 7

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA7 is a progressive form with highly variable age at onset and severity, even within families. The age at onset ranges from congenital to mid-adulthood.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.9 TPM
Pituitária
2.4 TPM
Tecido adiposo
0.9 TPM
Cervix Ectocervix
0.6 TPM
Esôfago - Junção
0.5 TPM
OUTRAS DOENÇAS (1)
autosomal dominant nonsyndromic hearing loss 7
HGNC:HGNC:6653UniProt:Q8TE12
RESTRE1-silencing transcription factorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional repressor which binds neuron-restrictive silencer element (NRSE) and represses neuronal gene transcription in non-neuronal cells (PubMed:11741002, PubMed:11779185, PubMed:12399542, PubMed:26551668, PubMed:7697725, PubMed:7871435, PubMed:8568247). Restricts the expression of neuronal genes by associating with two distinct corepressors, SIN3A and RCOR1, which in turn recruit histone deacetylase to the promoters of REST-regulated genes (PubMed:10449787, PubMed:10734093). Mediates re

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (5)
Regulation of PTEN gene transcriptionPotential therapeutics for SARSHDACs deacetylate histonesNGF-stimulated transcriptionRegulation of NPAS4 gene transcription
MECANISMO DE DOENÇA

Wilms tumor 6

A pediatric malignancy of kidney, and the most common childhood abdominal malignancy. It is caused by the uncontrolled multiplication of renal stem, stromal, and epithelial cells.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
18.7 TPM
Testículo
16.2 TPM
Linfócitos
15.0 TPM
Nervo tibial
14.5 TPM
Ovário
13.4 TPM
OUTRAS DOENÇAS (5)
fibromatosis, gingival, 5autosomal dominant nonsyndromic hearing loss 27hereditary gingival fibromatosiskidney Wilms tumor
HGNC:9966UniProt:Q13127
MYO3AMyosin-IIIaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Actin-dependent motor protein with a protein kinase activity, playing an essential role in hearing (PubMed:12032315, PubMed:29880844, PubMed:34788109). Probably also plays a role in vision. Required for normal cochlear hair bundle development and hearing. Plays an important role in the early steps of cochlear hair bundle morphogenesis. Influences the number and lengths of stereocilia to be produced and limits the growth of microvilli within the forming auditory hair bundles thereby contributing

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasmCell projection, filopodium tipCell projection, stereocilium

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 30

A form of non-syndromic deafness characterized by bilateral progressive hearing loss, which first affects the high frequencies. Hearing loss begins in the second decade, and by age 50 is severe in high and middle frequencies and moderate at low frequencies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
6.3 TPM
Artéria tibial
2.0 TPM
Brain Nucleus accumbens basal ganglia
1.3 TPM
Brain Caudate basal ganglia
0.7 TPM
Pituitária
0.6 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 90autosomal recessive nonsyndromic hearing loss 30hearing loss, autosomal recessive
HGNC:7601UniProt:Q8NEV4
RIPOR2Rho family-interacting cell polarization regulator 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as an inhibitor of the small GTPase RHOA and plays several roles in the regulation of myoblast and hair cell differentiation, lymphocyte T proliferation and neutrophil polarization (PubMed:17150207, PubMed:23241886, PubMed:24687993, PubMed:24958875, PubMed:25588844, PubMed:27556504). Inhibits chemokine-induced T lymphocyte responses, such as cell adhesion, polarization and migration (PubMed:23241886). Involved also in the regulation of neutrophil polarization, chemotaxis and adhesion (By si

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCell projection, filopodiumCell projection, stereociliumCell projection, stereocilium membraneApical cell membrane

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 104

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 21autosomal recessive nonsyndromic hearing loss 104hearing loss, autosomal recessive
HGNC:13872UniProt:Q9Y4F9
GREB1LGREB1-like proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a major role in early metanephros and genital development

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Renal hypodysplasia/aplasia 3

A severe, autosomal dominant disease encompassing a spectrum of kidney development defects. Clinical manifestations are highly variable and include bilateral or unilateral renal agenesis, renal aplasia, hypoplasia, (cystic) dysplasia, severe obstructive uropathy, and vesicoureteral reflux. Bilateral renal agenesis is almost invariably fatal in utero or in the perinatal period. Unilateral renal agenesis can lead to future health issues including end-stage renal disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fallopian Tube
8.7 TPM
Tireoide
7.4 TPM
Testículo
6.8 TPM
Ovário
6.4 TPM
Aorta
4.6 TPM
OUTRAS DOENÇAS (4)
hearing loss, autosomal dominant 80renal hypodysplasia/aplasia 3bilateral renal agenesisrenal agenesis, unilateral
HGNC:31042UniProt:Q9C091
GJB2Gap junction beta-2 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Structural component of gap junctions (PubMed:16849369, PubMed:17551008, PubMed:19340074, PubMed:19384972, PubMed:21094651, PubMed:26753910). Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane (PubMed:17551008, PubMed:19340074, PubMed:21094651, PubMed:26753910). Small molecules and ions diffuse from one cell to a neighboring cell via the central pore (PubMed:16849369, PubM

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (3)
Oligomerization of connexins into connexonsTransport of connexins along the secretory pathwayTransport of connexons to the plasma membrane
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 1A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
1032.4 TPM
Vagina
934.9 TPM
Skin Not Sun Exposed Suprapubic
76.3 TPM
Skin Sun Exposed Lower leg
75.7 TPM
Glândula salivar
21.6 TPM
OUTRAS DOENÇAS (12)
palmoplantar keratoderma-deafness syndromeichthyosis, hystrix-like, with hearing losskeratoderma hereditarium mutilansautosomal dominant keratitis-ichthyosis-hearing loss syndrome
HGNC:4284UniProt:P29033
USP48Ubiquitin carboxyl-terminal hydrolase 48Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Deubiquitinase that recognizes and hydrolyzes the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of polyubiquitin precursors as well as that of ubiquitinated proteins (PubMed:16214042, PubMed:34059922). Plays a role in the regulation of NF-kappa-B activation by TNF receptor superfamily via its interactions with RELA and TRAF2. May also play a regulatory role at postsynaptic sites. Plays an important role in cell cycle progression by deubiquitinating Aurora B/AURKB an

LOCALIZAÇÃO

CytoplasmNucleusCell projection, cilium

VIAS BIOLÓGICAS (1)
Ub-specific processing proteases
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 85

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA85 is characterized by progressive hearing loss, with onset in childhood or young adulthood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
68.8 TPM
Cérebro - Hemisfério cerebelar
55.8 TPM
Cerebelo
55.3 TPM
Ovário
36.8 TPM
Glândula adrenal
35.5 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 85autosomal dominant nonsyndromic hearing lossCushing disease due to pituitary adenoma
HGNC:18533UniProt:Q86UV5
DMXL2DmX-like protein 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May serve as a scaffold protein for MADD and RAB3GA on synaptic vesicles (PubMed:11809763). Plays a role in the brain as a key controller of neuronal and endocrine homeostatic processes (By similarity)

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membraneCytoplasmic vesicle, secretory vesicle, neuronal dense core vesicle

MECANISMO DE DOENÇA

Polyendocrine-polyneuropathy syndrome

A progressive endocrine and neurodevelopmental disorder manifesting early in childhood with growth retardation and recurrent episodes of profound asymptomatic hypoglycemia. PEPNS is characterized by central hypothyroidism, hypogonadotropic hypogonadism, incomplete puberty, progressive non-autoimmune insulin-dependent diabetes mellitus, peripheral demyelinating sensorimotor polyneuropathy, and cerebellar and pyramidal signs.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
22.0 TPM
Cerebelo
20.8 TPM
Pituitária
16.6 TPM
Pulmão
14.8 TPM
Testículo
13.9 TPM
OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 81polyendocrine-polyneuropathy syndromehearing loss, autosomal dominant 71early-infantile DEE
HGNC:2938UniProt:Q8TDJ6
TRRAPTransformation/transcription domain-associated proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Adapter protein, which is found in various multiprotein chromatin complexes with histone acetyltransferase activity (HAT), which gives a specific tag for epigenetic transcription activation. Component of the NuA4 histone acetyltransferase complex which is responsible for acetylation of nucleosomal histones H4 and H2A. Plays a central role in MYC transcription activation, and also participates in cell transformation by MYC. Required for p53/TP53-, E2F1- and E2F4-mediated transcription activation.

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
Formation of the beta-catenin:TCF transactivating complexHATs acetylate histonesUb-specific processing proteases
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
28.7 TPM
Pituitária
27.2 TPM
Testículo
25.9 TPM
Fibroblastos
25.3 TPM
Cerebelo
24.8 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 75developmental delay with or without dysmorphic facies and autismautosomal dominant nonsyndromic hearing loss
HGNC:12347UniProt:Q9Y4A5
KITLGKit ligandDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via

LOCALIZAÇÃO

Cell membraneCytoplasmCytoplasm, cytoskeletonCell projection, lamellipodiumCell projection, filopodiumSecreted

VIAS BIOLÓGICAS (1)
Signaling by SCF-KIT
MECANISMO DE DOENÇA

Hyperpigmentation with or without hypopigmentation, familial progressive

A disorder characterized by hyperpigmented patches in the skin, present in early infancy and increasing in size and number with age. Hyperpigmentation has variable intensity, and sometimes is associated with cafe-au-lait macules and larger hypopigmented ash-leaf macules.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
65.5 TPM
Esôfago - Muscular
42.9 TPM
Cólon sigmoide
35.5 TPM
Esôfago - Junção
34.5 TPM
Pulmão
33.7 TPM
OUTRAS DOENÇAS (8)
hyperpigmentation with or without hypopigmentation, familial progressiveWaardenburg syndrome, IIa 2Fautosomal dominant nonsyndromic hearing loss 69familial progressive hyperpigmentation
HGNC:6343UniProt:P21583
CRYMKetimine reductase mu-crystallinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the NAD(P)H-dependent reduction of imine double bonds of a number of cyclic ketimine substrates, including sulfur-containing cyclic ketimines (PubMed:21332720, PubMed:25931162). Under physiological conditions, it efficiently catalyzes delta(1)-piperideine-2-carboxylate (P2C) and delta(1)-pyrroline-2-carboxylate (Pyr2C) reduction, suggesting a central role in lysine and glutamate metabolism (PubMed:25931162). Additional substrates are delta(2)-thiazoline-2-carboxylate (T2C), 3,4-dehydro

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Lysine catabolism
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 40

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
153.7 TPM
Cérebro - Hemisfério cerebelar
150.5 TPM
Cerebelo
121.9 TPM
Brain Frontal Cortex BA9
90.3 TPM
Córtex cerebral
70.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 40autosomal dominant nonsyndromic hearing loss
HGNC:2418UniProt:Q14894
CCDC50Coiled-coil domain-containing protein 50Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in EGFR signaling

LOCALIZAÇÃO

Cytoplasm

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 44

A form of non-syndromic deafness characterized by initially moderate hearing loss that affects mainly low to mid frequencies. Later, it progresses to involve all the frequencies and leads to a profound hearing loss by the 6th decade.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 44autosomal dominant nonsyndromic hearing loss
HGNC:18111UniProt:Q8IVM0
DIABLODiablo IAP-binding mitochondrial proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Promotes apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Acts by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP). Inhibits the activity of BIRC6/BRUCE by inhibiting its binding to caspases (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106) Attenuates the stability and apoptosis-inhibiting activity of XIAP/BIRC4 by promoting XIAP/BIRC4 ubiquitination and degradation through the ubiquitin-proteasome pathway. Also disrupts X

LOCALIZAÇÃO

MitochondrionCytoplasm, cytosol

VIAS BIOLÓGICAS (5)
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes SMAC (DIABLO) binds to IAPs SMAC, XIAP-regulated apoptotic responseRelease of apoptotic factors from the mitochondriaRegulation of the apoptosome activity
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 64

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
33.2 TPM
Pituitária
18.1 TPM
Fibroblastos
15.9 TPM
Linfócitos
15.9 TPM
Ovário
13.0 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 64autosomal dominant nonsyndromic hearing loss
HGNC:21528UniProt:Q9NR28
HOMER2Homer protein homolog 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Postsynaptic density scaffolding protein. Binds and cross-links cytoplasmic regions of GRM1, GRM5, ITPR1, DNM3, RYR1, RYR2, SHANK1 and SHANK3. By physically linking GRM1 and GRM5 with ER-associated ITPR1 receptors, it aids the coupling of surface receptors to intracellular calcium release. May also couple GRM1 to PI3 kinase through its interaction with AGAP2. Isoforms can be differently regulated and may play an important role in maintaining the plasticity at glutamatergic synapses (PubMed:98084

LOCALIZAÇÃO

CytoplasmCell membranePostsynaptic densitySynapseCell projection, stereocilium

VIAS BIOLÓGICAS (1)
Neurexins and neuroligins
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 68

A form of non-syndromic sensorineural hearing loss with postlingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Pâncreas
24.0 TPM
Glândula salivar
20.2 TPM
Próstata
16.3 TPM
Skin Sun Exposed Lower leg
15.1 TPM
Estômago
13.8 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 68autosomal dominant nonsyndromic hearing loss
HGNC:17513UniProt:Q9NSB8
SLC44A4Choline transporter-like protein 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Choline transporter that plays a role in the choline-acetylcholine system and is required to the efferent innervation of hair cells in the olivocochlear bundle for the maintenance of physiological function of outer hair cells and the protection of hair cells from acoustic injury (By similarity) (PubMed:23651124, PubMed:28013291). Also described as a thiamine pyrophosphate transporter in colon, may mediate the absorption of microbiota-generated thiamine pyrophosphate and contribute to host thiami

LOCALIZAÇÃO

MembraneApical cell membrane

VIAS BIOLÓGICAS (2)
Synthesis of PCSLC-mediated bile acid transport
EXPRESSÃO TECIDUAL(Tecido-específico)
Próstata
148.6 TPM
Cólon transverso
147.1 TPM
Intestino delgado
93.0 TPM
Estômago
83.9 TPM
Glândula salivar
52.5 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 72autosomal dominant nonsyndromic hearing loss
HGNC:13941UniProt:Q53GD3
POU4F3POU domain, class 4, transcription factor 3Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Acts as a transcriptional activator (PubMed:18228599). Acts by binding to sequences related to the consensus octamer motif 5'-ATGCAAAT-3' in the regulatory regions of its target genes (PubMed:18228599). Involved in the auditory system development, required for terminal differentiation of hair cells in the inner ear (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 15

A form of non-syndromic hearing loss with variable phenotype in terms of age at onset, levels of progression, and shape of audiograms.

EXPRESSÃO TECIDUAL(Não detectado)
Nervo tibial
0.2 TPM
Aorta
0.2 TPM
Artéria tibial
0.2 TPM
Skin Sun Exposed Lower leg
0.2 TPM
Brain Spinal cord cervical c-1
0.1 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 15autosomal dominant nonsyndromic hearing loss
HGNC:9220UniProt:Q15319
MYH9Myosin-9Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Required for cortical actin clearance prior to oocyte exocytosis (By similarity). Promotes cell motility in conjunction with S100A4 (PubMed:16707441). During cell spreading, plays an important role in cytoskeleton reorganization, focal contact formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanic

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cell cortexCytoplasmic vesicle, secretory vesicle, Cortical granuleCell membrane

VIAS BIOLÓGICAS (10)
RHO GTPases activate PAKsRHO GTPases Activate ROCKsRHO GTPases activate PKNsRHO GTPases activate CITSema4D induced cell migration and growth-cone collapse
MECANISMO DE DOENÇA

Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss

An autosomal dominant disorder characterized by thrombocytopenia, giant platelets and Dohle body-like inclusions in peripheral blood leukocytes with variable ultrastructural appearance. Some affected individuals lack leukocyte inclusion bodies on classic staining of peripheral blood smears. Alport syndrome-like features of nephritis, hearing loss, and eye abnormalities are present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
1592.3 TPM
Artéria tibial
1091.7 TPM
Útero
820.6 TPM
Artéria coronária
818.3 TPM
Pulmão
601.2 TPM
OUTRAS DOENÇAS (4)
autosomal dominant nonsyndromic hearing loss 17macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing lossnodular fasciitisautosomal dominant nonsyndromic hearing loss
HGNC:7579UniProt:P35579
GSDMEGasdermin-EDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Precursor of a pore-forming protein that converts non-inflammatory apoptosis to pyroptosis (PubMed:27281216, PubMed:28459430, PubMed:33852854, PubMed:35594856, PubMed:36607699). This form constitutes the precursor of the pore-forming protein: upon cleavage, the released N-terminal moiety (Gasdermin-E, N-terminal) binds to membranes and forms pores, triggering pyroptosis (PubMed:28459430) Pore-forming protein produced by cleavage by CASP3 or granzyme B (GZMB), which converts non-inflammatory apop

LOCALIZAÇÃO

Cell membraneCytoplasm, cytosol

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 5

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 5autosomal dominant nonsyndromic hearing loss
HGNC:2810UniProt:O60443
GJB6Gap junction beta-6 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Ectodermal dysplasia 2, Clouston type

A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ECTD2 is an autosomal dominant condition characterized by atrichosis, nail hypoplasia and deformities, hyperpigmentation of the skin, normal teeth, normal sweat and sebaceous gland function. Palmoplantar hyperkeratosis is a frequent feature. Hearing impairment has been detected in few cases.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Esôfago - Mucosa
199.5 TPM
Vagina
198.2 TPM
Skin Sun Exposed Lower leg
51.2 TPM
Córtex cerebral
51.0 TPM
Skin Not Sun Exposed Suprapubic
48.1 TPM
OUTRAS DOENÇAS (7)
autosomal recessive nonsyndromic hearing loss 1Bautosomal recessive nonsyndromic hearing loss 1AClouston syndromeautosomal dominant nonsyndromic hearing loss 3B
HGNC:4288UniProt:O95452
WFS1WolframinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Participates in the regulation of cellular Ca(2+) homeostasis, at least partly, by modulating the filling state of the endoplasmic reticulum Ca(2+) store (PubMed:16989814). Negatively regulates the ER stress response and positively regulates the stability of V-ATPase subunits ATP6V1A and ATP1B1 by preventing their degradation through an unknown proteasome-independent mechanism (PubMed:23035048)

LOCALIZAÇÃO

Endoplasmic reticulum membraneCytoplasmic vesicle, secretory vesicle

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Wolfram syndrome 1

A rare disorder characterized by juvenile-onset insulin-dependent diabetes mellitus with optic atrophy. Other manifestations include diabetes insipidus, sensorineural deafness, dementia, psychiatric illnesses.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
209.9 TPM
Útero
191.1 TPM
Aorta
160.6 TPM
Fallopian Tube
157.4 TPM
Artéria tibial
151.6 TPM
OUTRAS DOENÇAS (8)
Wolfram syndrome 1Wolfram-like syndromeautosomal dominant nonsyndromic hearing loss 6cataract 41
HGNC:12762UniProt:O76024
TECTAAlpha-tectorinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

One of the major non-collagenous components of the tectorial membrane (By similarity). The tectorial membrane is an extracellular matrix of the inner ear that covers the neuroepithelium of the cochlea and contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals

LOCALIZAÇÃO

Cell membraneSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Post-translational modification: synthesis of GPI-anchored proteins
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 12

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cerebelo
3.3 TPM
Pituitária
3.0 TPM
Cérebro - Hemisfério cerebelar
2.9 TPM
Testículo
2.7 TPM
Tireoide
2.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (5)
autosomal dominant nonsyndromic hearing loss 12autosomal recessive nonsyndromic hearing loss 21nonsyndromic genetic hearing losshearing loss, autosomal recessive
HGNC:11720UniProt:O75443
MCM2DNA replication licensing factor MCM7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are form

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (7)
Activation of ATR in response to replication stressActivation of the pre-replicative complexOrc1 removal from chromatinUnwinding of DNAAssembly of the pre-replicative complex
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
137.4 TPM
Testículo
24.9 TPM
Fibroblastos
22.0 TPM
Esôfago - Mucosa
12.7 TPM
Baço
12.3 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 70autosomal dominant nonsyndromic hearing loss
HGNC:6944UniProt:P33993
TNCTenascinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Extracellular matrix protein implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity as well as neuronal regeneration. Promotes neurite outgrowth from cortical neurons grown on a monolayer of astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-V/beta-6. In tumors, stimulates angiogenesis by elongation, migration and sprouting of endothelial cells (PubMed:19884327)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 56

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA56 is characterized by progressive hearing impairment with postlingual onset.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
351.7 TPM
Cólon sigmoide
199.3 TPM
Fibroblastos
99.0 TPM
Rim - Medula
83.0 TPM
Artéria coronária
77.4 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 56autosomal dominant nonsyndromic hearing loss
HGNC:5318UniProt:P24821
ACTG1Actin, cytoplasmic 2Disease-causing germline mutation(s) inModerado
FUNÇÃO

Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (10)
Paradoxical activation of RAF signaling by kinase inactive BRAFSignaling by moderate kinase activity BRAF mutantsSignaling by high-kinase activity BRAF mutantsSignaling downstream of RAS mutantsMAP2K and MAPK activation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 20

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (6)
autosomal dominant nonsyndromic hearing loss 20Baraitser-winter syndrome 2Baraitser-Winter cerebrofrontofacial syndromecoloboma of iris
HGNC:144UniProt:P63261
EYA4Protein phosphatase EYA4Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. Its function as histone phosphatase probably explains its role in transcription regulation during organog

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 10

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
16.8 TPM
Próstata
5.8 TPM
Pituitária
5.6 TPM
Cervix Endocervix
5.1 TPM
Cervix Ectocervix
3.9 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 10dilated cardiomyopathy 1Jautosomal dominant nonsyndromic hearing loss
HGNC:3522UniProt:O95677
MIR96Disease-causing germline mutation(s) inDesconhecido
LOCALIZAÇÃO

OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 50autosomal dominant nonsyndromic hearing loss
HGNC:31648
MYO1AUnconventional myosin-IaCandidate gene tested inTolerante
FUNÇÃO

Involved in directing the movement of organelles along actin filaments

LOCALIZAÇÃO

Cell projection, microvillus

MECANISMO DE DOENÇA

Diarrhea 15, congenital

An autosomal recessive disorder characterized by severe diarrhea manifesting in infancy and resolving by the second year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
103.4 TPM
Cólon transverso
51.6 TPM
Brain Spinal cord cervical c-1
9.6 TPM
Estômago
4.3 TPM
Testículo
2.7 TPM
OUTRAS DOENÇAS (2)
diarrhea 15, congenitalautosomal dominant nonsyndromic hearing loss
HGNC:7595UniProt:Q9UBC5
COL11A1Collagen alpha-1(XI) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Stickler syndrome 2

An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable.

OUTRAS DOENÇAS (8)
Marshall syndromeStickler syndrome type 2hearing loss, autosomal dominant 37fibrochondrogenesis 1
HGNC:2186UniProt:P12107
SSBP1Single-stranded DNA-binding protein, mitochondrialMajor susceptibility factor inTolerante
FUNÇÃO

Binds preferentially and cooperatively to pyrimidine rich single-stranded DNA (ss-DNA) (PubMed:21953457, PubMed:23290262, PubMed:31550240). In vitro, required to maintain the copy number of mitochondrial DNA (mtDNA) and plays a crucial role during mtDNA replication by stimulating the activity of the replisome components POLG and TWNK at the replication fork (PubMed:12975372, PubMed:15167897, PubMed:21953457, PubMed:26446790, PubMed:31550240). Promotes the activity of the gamma complex polymerase

LOCALIZAÇÃO

MitochondrionMitochondrion matrix, mitochondrion nucleoid

VIAS BIOLÓGICAS (3)
Strand-asynchronous mitochondrial DNA replicationMitochondrial protein degradationTranscriptional activation of mitochondrial biogenesis
MECANISMO DE DOENÇA

Optic atrophy 13 with retinal and foveal abnormalities

An autosomal dominant disease characterized by visual impairment in association with bilateral optic atrophy. Atrophy of the optic disk indicates a deficiency in the number of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. Many OPA13 patients also exhibit retinal pigmentary defects, attenuated retinal vasculature, macular dystrophy, and foveopathy. Some patients may develop additional systemic features, including sensorineural deafness and progressive nephropathy resulting in renal failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
151.8 TPM
Fibroblastos
127.4 TPM
Artéria tibial
80.8 TPM
Testículo
78.2 TPM
Ovário
74.8 TPM
OUTRAS DOENÇAS (2)
optic atrophy 13 with retinal and foveal abnormalitiesautosomal dominant nonsyndromic hearing loss
HGNC:11317UniProt:Q04837
ABCC1Multidrug resistance-associated protein 1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Mediates export of organic anions and drugs from the cytoplasm (PubMed:10064732, PubMed:11114332, PubMed:16230346, PubMed:7961706, PubMed:9281595). Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics (PubMed:10064732, PubMed:11114332, PubMed:16230346, PubMed:7961706, PubMed:9281595). Confers resistance to anticancer drugs by decreasing accumulation of drug in cells, and by

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (8)
Transport of RCbl within the bodyCytoprotection by HMOX1Heme degradationSynthesis of Leukotrienes (LT) and Eoxins (EX)Sphingolipid de novo biosynthesis
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 77

A form of non-syndromic deafness characterized by adult onset of bilateral, postlingual, mild-to-severe sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 77autosomal dominant nonsyndromic hearing loss
HGNC:51UniProt:P33527
PLS1Plastin-1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Actin-bundling protein. In the inner ear, it is required for stereocilia formation. Mediates liquid packing of actin filaments that is necessary for stereocilia to grow to their proper dimensions

LOCALIZAÇÃO

CytoplasmCell projection, stereocilium

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 76

A form of non-syndromic deafness characterized by mild to profound sensorineural hearing loss and variable age at onset. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
34.2 TPM
Cólon transverso
31.1 TPM
Pituitária
9.8 TPM
Glândula salivar
9.4 TPM
Esôfago - Mucosa
9.2 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 76autosomal dominant nonsyndromic hearing loss
HGNC:9090UniProt:Q14651
TMC1Transmembrane channel-like protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming subunit of the mechanotransducer (MET) non-selective cation channel complex located at the tips of stereocilia of cochlear hair cells and that mediates sensory transduction in the auditory system (By similarity). The MET complex is composed of two dimeric pore-forming ion-conducting transmembrane TMC (TMC1 or TMC2) subunits, and aided by several auxiliary proteins including LHFPL5, TMIE, CIB2/3 and TOMT, and the tip-link PCDH15 (By similarity). MET channel is activated by tension in

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 36

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA36 is a bilateral hearing loss, and begins at 5-10 years of age. It progresses to profound deafness within 10-15 years.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.4 TPM
Esôfago - Mucosa
0.7 TPM
Brain Spinal cord cervical c-1
0.6 TPM
Próstata
0.4 TPM
Vagina
0.3 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 7autosomal dominant nonsyndromic hearing loss 36autosomal dominant nonsyndromic hearing losshearing loss, autosomal recessive
HGNC:16513UniProt:Q8TDI8
TJP2Tight junction protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in tight junctions and adherens junctions (By similarity). Acts as a positive regulator of RANKL-induced osteoclast differentiation, potentially via mediating downstream transcriptional activity (By similarity)

LOCALIZAÇÃO

Cell junction, adherens junctionCell membraneCell junction, tight junctionNucleus

VIAS BIOLÓGICAS (1)
Signaling by Hippo
MECANISMO DE DOENÇA

Hypercholanemia, familial, 1

A disorder characterized by elevated serum bile acid concentrations, itching, and fat malabsorption.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
103.6 TPM
Nervo tibial
85.5 TPM
Pulmão
84.2 TPM
Tecido adiposo
81.3 TPM
Tireoide
80.0 TPM
OUTRAS DOENÇAS (3)
cholestasis, progressive familial intrahepatic, 4hypercholanemia, familial 1autosomal dominant nonsyndromic hearing loss
HGNC:11828UniProt:Q9UDY2
MYO7AUnconventional myosin-VIIaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. In the retina, plays an important role in the renewal of the outer photoreceptor disks. Plays an important role in the distribution and migration of retinal pigment epithelial (RPE) melanosomes and phagosomes, and in the regulation of opsin transport in retinal photore

LOCALIZAÇÃO

CytoplasmCytoplasm, cell cortexCytoplasm, cytoskeletonSynapse

VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1B

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
43.8 TPM
Glândula adrenal
40.7 TPM
Pituitária
27.6 TPM
Baço
20.4 TPM
Fígado
12.7 TPM
OUTRAS DOENÇAS (9)
autosomal dominant nonsyndromic hearing loss 11autosomal recessive nonsyndromic hearing loss 2Usher syndrome type 1Bnonsyndromic genetic hearing loss
HGNC:7606UniProt:Q13402
TBC1D24TBC1 domain family member 24Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May act as a GTPase-activating protein for Rab family protein(s) (PubMed:20727515, PubMed:20797691). Involved in neuronal projections development, probably through a negative modulation of ARF6 function (PubMed:20727515). Involved in the regulation of synaptic vesicle trafficking (PubMed:31257402)

LOCALIZAÇÃO

Cell membraneCytoplasmCytoplasmic vesicle membranePresynapse

VIAS BIOLÓGICAS (1)
TBC/RABGAPs
MECANISMO DE DOENÇA

Familial infantile myoclonic epilepsy

A subtype of idiopathic epilepsy starting in early infancy and manifesting as myoclonic seizures, febrile convulsions, and tonic-clonic seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
27.8 TPM
Cérebro - Hemisfério cerebelar
26.6 TPM
Brain Frontal Cortex BA9
11.4 TPM
Córtex cerebral
11.2 TPM
Pituitária
9.4 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (11)
familial infantile myoclonic epilepsyrolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndromeautosomal dominant nonsyndromic hearing loss 65autosomal recessive nonsyndromic hearing loss 86
HGNC:29203UniProt:Q9ULP9
KCNQ4Potassium voltage-gated channel subfamily KQT member 4Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Pore-forming subunit of the voltage-gated potassium (Kv) channel involved in the regulation of sensory cells excitability in the cochlea (PubMed:10025409, PubMed:34767770). KCNQ4/Kv7.4 channel is composed of 4 pore-forming subunits assembled as tetramers (PubMed:34767770). Promotes the outflow of potassium ions in the repolarization phase of action potential which plays a role in regulating membrane potential of excitable cells (PubMed:10025409, PubMed:11245603, PubMed:34767770). The channel con

LOCALIZAÇÃO

Basal cell membrane

VIAS BIOLÓGICAS (3)
Voltage gated Potassium channelsSensory processing of sound by inner hair cells of the cochleaSensory processing of sound by outer hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 2A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
34.4 TPM
Esôfago - Muscular
29.5 TPM
Esôfago - Junção
26.7 TPM
Artéria tibial
20.7 TPM
Útero
19.5 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 2Anonsyndromic genetic hearing lossautosomal dominant nonsyndromic hearing loss
HGNC:6298UniProt:P56696
MYH14Myosin-14Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping

LOCALIZAÇÃO

VIAS BIOLÓGICAS (6)
RHO GTPases activate PAKsRHO GTPases Activate ROCKsRHO GTPases activate PKNsRHO GTPases activate CITSema4D induced cell migration and growth-cone collapse
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 4A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
109.7 TPM
Músculo esquelético
106.9 TPM
Skin Not Sun Exposed Suprapubic
97.8 TPM
Esôfago - Mucosa
66.6 TPM
Tireoide
53.2 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 4Aperipheral neuropathy-myopathy-hoarseness-hearing loss syndromeautosomal dominant nonsyndromic hearing loss
HGNC:23212UniProt:Q7Z406
CD164Sialomucin core protein 24Disease-causing germline mutation(s) inModerado
FUNÇÃO

Sialomucin that may play a key role in hematopoiesis by facilitating the adhesion of CD34(+) cells to the stroma and by negatively regulating CD34(+)CD38(lo/-) cell proliferation. Modulates the migration of umbilical cord blood CD133+ cells and this is mediated through the CXCL12/CXCR4 axis. May play an important role in prostate cancer metastasis and the infiltration of bone marrow by cancer cells. Promotes myogenesis by enhancing CXCR4-dependent cell motility. Positively regulates myoblast mig

LOCALIZAÇÃO

Lysosome membraneEndosome membraneCell membraneSecreted

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 66

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 66autosomal dominant nonsyndromic hearing loss
HGNC:1632UniProt:Q04900
COL11A2Collagen alpha-2(XI) chainDisease-causing germline mutation(s) inRestrito
FUNÇÃO

May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Collagen biosynthesis and modifying enzymesCollagen chain trimerization
MECANISMO DE DOENÇA

Otospondylomegaepiphyseal dysplasia, autosomal dominant

An autosomal dominant form of otospondylomegaepiphyseal dysplasia, a disorder characterized by sensorineural deafness, enlarged epiphyses, mild platyspondyly, and disproportionate shortness of the limbs. Total body length is normal. Typical facial features are mid-face hypoplasia, short upturned nose and depressed nasal bridge. Most patients have Pierre Robin sequence including an opening in the roof of the mouth (cleft palate) and a small lower jaw (micrognathia). Ocular symptoms are absent. Some patients have early-onset osteoarthritis.

OUTRAS DOENÇAS (9)
otospondylomegaepiphyseal dysplasia, autosomal dominantotospondylomegaepiphyseal dysplasia, autosomal recessiveautosomal dominant nonsyndromic hearing loss 13autosomal recessive nonsyndromic hearing loss 53
HGNC:2187UniProt:P13942
GRHL2Grainyhead-like protein 2 homologDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor playing an important role in primary neurulation and in epithelial development (PubMed:25152456, PubMed:29309642). Binds directly to the consensus DNA sequence 5'-AACCGGTT-3' acting as an activator and repressor on distinct target genes (By similarity). During embryogenesis, plays unique and cooperative roles with GRHL3 in establishing distinct zones of primary neurulation. Essential for closure 3 (rostral end of the forebrain), functions cooperatively with GRHL3 in closure

LOCALIZAÇÃO

NucleusMembrane

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 28

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA28 is characterized by mild to moderate hearing loss across most frequencies that progresses to severe loss in the higher frequencies by the fifth decade.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
41.4 TPM
Skin Sun Exposed Lower leg
39.8 TPM
Próstata
34.7 TPM
Esôfago - Mucosa
33.1 TPM
Glândula salivar
24.8 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (5)
autosomal dominant nonsyndromic hearing loss 28corneal dystrophy, posterior polymorphous, 4nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeposterior polymorphous corneal dystrophy
HGNC:2799UniProt:Q6ISB3
MYO6Unconventional myosin-VIDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity (By similarity). Unconventional myosins serve in intracellular movements (By similarity). Myosin 6 is a reverse-direction motor protein that moves towards the minus-end of actin filaments (PubMed:10519557). Has slow rate of actin-activated ADP release due to weak ATP binding (By similarity). Functions in a variety of intracellular processes such as vesicular membrane trafficking and cell migration (By similarity). Required for the stru

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneGolgi apparatusNucleusCytoplasm, perinuclear regionMembrane, clathrin-coated pitCytoplasmic vesicle, clathrin-coated vesicleCell projection, filopodiumCell projection, ruffle membraneCell projection, microvillusCytoplasm, cytosolCytoplasmic vesicle, autophagosomeEndosomeCytoplasmic vesicle, clathrin-coated vesicle membrane

VIAS BIOLÓGICAS (4)
Trafficking of AMPA receptorsRHOU GTPase cycleRHOBTB2 GTPase cycleRHOBTB1 GTPase cycle
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 22

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA22 is progressive and postlingual, with onset during childhood. By the age of approximately 50 years, affected individuals invariably have profound sensorineural deafness.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
31.4 TPM
Rim - Medula
29.8 TPM
Esôfago - Mucosa
29.7 TPM
Cérebro - Hemisfério cerebelar
28.1 TPM
Cerebelo
28.0 TPM
OUTRAS DOENÇAS (6)
autosomal recessive nonsyndromic hearing loss 37autosomal dominant nonsyndromic hearing loss 22nonsyndromic genetic hearing lossprogressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome
HGNC:7605UniProt:Q9UM54
MYO1CUnconventional myosin-IcDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Involved in glucose transporter recycling in response to insulin by regulating movement of intracellular GLUT4-containing vesicles to the plasma membrane. Component of the hair cell's (the sensory cells of the inner ear) adaptation-motor complex. Acts a

LOCALIZAÇÃO

CytoplasmNucleusCytoplasm, cell cortexCell projection, stereocilium membraneCytoplasmic vesicleCell projection, ruffle membraneNucleus, nucleoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (5)
Regulation of actin dynamics for phagocytic cup formationFCGR3A-mediated phagocytosisSensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochleaTranslocation of SLC2A4 (GLUT4) to the plasma membrane
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
213.8 TPM
Tecido adiposo
207.3 TPM
Aorta
184.2 TPM
Nervo tibial
182.3 TPM
Esôfago - Muscular
174.3 TPM
OUTRAS DOENÇAS (1)
autosomal dominant nonsyndromic hearing loss
HGNC:7597UniProt:O00159
OSBPL2Oxysterol-binding protein-related protein 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Intracellular transport protein that binds sterols and phospholipids and mediates lipid transport between intracellular compartments. Increases plasma membrane cholesterol levels and decreases phosphatidylinositol-4,5-bisphosphate levels in the cell membrane (PubMed:30581148). Binds phosphoinositides, such as phosphatidylinositol-4,5-bisphosphate (PubMed:30581148). Exhibits strong binding to phosphatidic acid and weak binding to phosphatidylinositol 3-phosphate (PubMed:11279184). Binds cholester

LOCALIZAÇÃO

Cytoplasm, cytosolLipid dropletCell membrane

VIAS BIOLÓGICAS (1)
Synthesis of bile acids and bile salts
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 67

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
53.2 TPM
Cerebelo
52.3 TPM
Skin Not Sun Exposed Suprapubic
41.8 TPM
Skin Sun Exposed Lower leg
40.4 TPM
Vagina
32.1 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 67autosomal dominant nonsyndromic hearing loss
HGNC:15761UniProt:Q9H1P3
GJB3Gap junction beta-3 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Erythrokeratodermia variabilis et progressiva 1

A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
184.0 TPM
Skin Not Sun Exposed Suprapubic
182.9 TPM
Esôfago - Mucosa
87.3 TPM
Vagina
41.6 TPM
Próstata
4.5 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (7)
autosomal dominant nonsyndromic hearing loss 2Bautosomal recessive nonsyndromic hearing loss 1Aerythrokeratodermia variabilis et progressiva 1hearing loss, autosomal recessive
HGNC:4285UniProt:O75712
P2RX2P2X purinoceptor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

ATP-gated nonselective transmembrane cation channel permeable to potassium, sodium and calcium (PubMed:10570044, PubMed:31636190). Activation by extracellular ATP induces a variety of cellular responses, such as excitatory postsynaptic responses in sensory neurons, neuromuscular junctions (NMJ) formation, hearing, perception of taste and peristalsis (By similarity). In the inner ear, regulates sound transduction and auditory neurotransmission, outer hair cell electromotility, inner ear gap junct

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Elevation of cytosolic Ca2+ levelsPlatelet homeostasis
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 41

A form of non-syndromic deafness characterized by onset of progressive sensorineural hearing loss usually in the second decade. The hearing loss is severe and ultimately affects all frequencies. Exposure to noise exacerbates the hearing loss, particularly at high frequencies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Próstata
17.3 TPM
Esôfago - Junção
12.0 TPM
Esôfago - Muscular
8.6 TPM
Pulmão
6.3 TPM
Fallopian Tube
5.1 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 41autosomal dominant nonsyndromic hearing loss
HGNC:15459UniProt:Q9UBL9
DIAPH3Protein diaphanous homolog 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Actin nucleation and elongation factor required for the assembly of F-actin structures, such as actin cables and stress fibers. Required for cytokinesis, stress fiber formation and transcriptional activation of the serum response factor. Binds to GTP-bound form of Rho and to profilin: acts in a Rho-dependent manner to recruit profilin to the membrane, where it promotes actin polymerization. DFR proteins couple Rho and Src tyrosine kinase during signaling and the regulation of actin dynamics. Als

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
RHO GTPases Activate ForminsRAC3 GTPase cycleRHOJ GTPase cycleRHOG GTPase cycleRHOF GTPase cycle
MECANISMO DE DOENÇA

Auditory neuropathy, autosomal dominant 1

A form of sensorineural hearing loss with absent or severely abnormal auditory brainstem response, in the presence of normal cochlear outer hair cell function and normal otoacoustic emissions. Auditory neuropathies result from a lesion in the area including the inner hair cells, connections between the inner hair cells and the cochlear branch of the auditory nerve, the auditory nerve itself and auditory pathways of the brainstem. Affected individuals typically respond to sound but have difficulties in speech discrimination.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
20.9 TPM
Linfócitos
15.0 TPM
Fibroblastos
11.9 TPM
Esôfago - Mucosa
2.7 TPM
Aorta
2.5 TPM
OUTRAS DOENÇAS (2)
autosomal dominant auditory neuropathy 1autosomal dominant nonsyndromic hearing loss
HGNC:15480UniProt:Q9NSV4
ATP11APhospholipid-transporting ATPase IHDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids, phosphatidylserines (PS) and phosphatidylethanolamines (PE), from the outer to the inner leaflet of the plasma membrane (PubMed:25315773, PubMed:25947375, PubMed:26567335, PubMed:29799007, PubMed:30018401, PubMed:36300302). Does not show flippase activity toward phosphatidylcholine (PC) (PubMed:34403372). Contributes to the maintenance of membrane lipid asymme

LOCALIZAÇÃO

Cell membraneEarly endosomeRecycling endosomeEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 84

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA84 is characterized by slowly progressive, postlingual hearing loss.

OUTRAS DOENÇAS (5)
leukodystrophy, hypomyelinating, 24hearing loss, autosomal dominant 84auditory neuropathy, autosomal dominant 2idiopathic pulmonary fibrosis
HGNC:13552UniProt:P98196
PTPRQPhosphatidylinositol phosphatase PTPRQDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Dephosphorylates phosphatidylinositol phosphates, such as phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 3,5-diphosphates, with preference for PIP3 (PubMed:23897475). Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring (PubMed:23897475). Has low tyrosine-protein phosphatase activity in vitro; however, the relevance of such activity in vivo is unclear (By similarity). Plays an important role in adipogenesis of mesenchymal stem cells (MSCs). Regu

LOCALIZAÇÃO

Cell projection, stereociliumApical cell membraneBasal cell membrane

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 84A

A form of non-syndromic deafness characterized by progressive, sensorineural hearing loss and vestibular dysfunction.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.0 TPM
Fibroblastos
4.0 TPM
Rim - Córtex
3.1 TPM
Adipose Visceral Omentum
2.5 TPM
Pulmão
1.5 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 84Ahearing loss, autosomal dominant 73hearing loss, autosomal recessiveautosomal dominant nonsyndromic hearing loss
HGNC:9679UniProt:Q9UMZ3
SIX1Homeobox protein SIX1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Transcription factor that is involved in the regulation of cell proliferation, apoptosis and embryonic development (By similarity). Plays an important role in the development of several organs, including kidney, muscle and inner ear (By similarity). Depending on context, functions as a transcriptional repressor or activator (By similarity). Lacks an activation domain, and requires interaction with EYA family members for transcription activation (PubMed:15141091). Mediates nuclear translocation o

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Formation of the ureteric bud
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 23

A form of non-syndromic deafness characterized by prelingual, bilateral, symmetric hearing loss with a conductive component present in some but not all patients.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pituitária
30.7 TPM
Músculo esquelético
30.5 TPM
Fibroblastos
14.8 TPM
Próstata
12.4 TPM
Glândula salivar
10.5 TPM
OUTRAS DOENÇAS (5)
branchiootic syndrome 3autosomal dominant nonsyndromic hearing loss 23branchiootic syndromebranchio-oto-renal syndrome
HGNC:10887UniProt:Q15475
COCHCochlinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the control of cell shape and motility in the trabecular meshwork

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 9

A form of non-syndromic hearing loss characterized by onset in the fourth or fifth decade of life and initially involves the high frequencies. Hearing loss is progressive and usually complete by the sixth decade. In addition to cochlear involvement, DFNA9 patients also exhibit a spectrum of vestibular dysfunctions. Penetrance of the vestibular symptoms is often incomplete, and some patients are minimally affected, whereas others suffer from severe balance disturbances and episodes of vertigo. Affected individuals have mucopolysaccharide depositions in the channels of the cochlear and vestibular nerves. These depositions apparently cause strangulation and degeneration of dendritic fibers.

OUTRAS DOENÇAS (4)
autosomal dominant nonsyndromic hearing loss 9hearing loss, autosomal recessive 110nonsyndromic genetic hearing lossautosomal dominant nonsyndromic hearing loss
HGNC:2180UniProt:O43405
CENPPCentromere protein PDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex

LOCALIZAÇÃO

NucleusChromosome, centromere

VIAS BIOLÓGICAS (6)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
OUTRAS DOENÇAS (1)
autosomal dominant nonsyndromic hearing loss
HGNC:32933UniProt:Q6IPU0
CEACAM16Cell adhesion molecule CEACAM16Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for proper hearing, plays a role in maintaining the integrity of the tectorial membrane

LOCALIZAÇÃO

Secreted

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 4B

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
hearing loss, autosomal recessive 113autosomal dominant nonsyndromic hearing loss 4Bhearing loss, autosomal recessiveautosomal dominant nonsyndromic hearing loss
HGNC:31948UniProt:Q2WEN9
MAP1BMicrotubule-associated protein 1BDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DA

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasmSynapseCell projection, dendritic spine

VIAS BIOLÓGICAS (1)
RSV-host interactions
MECANISMO DE DOENÇA

Periventricular nodular heterotopia 9

A form of periventricular nodular heterotopia, a disorder resulting from a defect in the pattern of neuronal migration in which ectopic collections of neurons lie along the lateral ventricles of the brain or just beneath, contiguously or in isolated patches. PVNH9 is an autosomal dominant disorder with incomplete penetrance, characterized by impaired intellectual development, cognitive defects, learning disabilities, and behavior abnormalities. Some patients develop seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
262.6 TPM
Cerebelo
227.2 TPM
Brain Frontal Cortex BA9
180.1 TPM
Aorta
169.2 TPM
Brain Spinal cord cervical c-1
158.9 TPM
OUTRAS DOENÇAS (4)
periventricular nodular heterotopia 9hearing loss, autosomal dominant 83periventricular nodular heterotopiaautosomal dominant nonsyndromic hearing loss
HGNC:6836UniProt:P46821
PDE1CDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Calmodulin-dependent cyclic nucleotide phosphodiesterase with a dual specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:29860631, PubMed:8557689). Has a high affinity for both cAMP and cGMP (PubMed:8557689). Modulates the amplitude and duration of the cAMP signal in sensory cilia in response to odorant stimulation, hence contributing to the generation of action potentials. Regulates smooth muscle cell proliferation. Reg

LOCALIZAÇÃO

Lysosome

VIAS BIOLÓGICAS (1)
Cam-PDE 1 activation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 74

A form of non-syndromic deafness characterized by progressive, postlingual hearing loss with onset in the third decade of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
14.4 TPM
Brain Spinal cord cervical c-1
13.3 TPM
Fallopian Tube
12.2 TPM
Coração - Átrio
9.9 TPM
Bladder
8.4 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 74autosomal dominant nonsyndromic hearing loss
HGNC:8776UniProt:Q14123

Variantes genéticas (ClinVar)

203 variantes patogênicas registradas no ClinVar.

🧬 SLC17A8: NM_139319.3(SLC17A8):c.578G>T (p.Gly193Val) ()
🧬 SLC17A8: GRCh37/hg19 12q23.1-24.33(chr12:99532287-133777902)x3 ()
🧬 SLC17A8: NM_139319.3(SLC17A8):c.869G>T (p.Ser290Ile) ()
🧬 SLC17A8: NM_139319.3(SLC17A8):c.1651A>G (p.Thr551Ala) ()
🧬 SLC17A8: NM_139319.3(SLC17A8):c.83C>G (p.Ser28Cys) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

142 vias biológicas associadas aos genes desta condição.

SLC-mediated transport of neurotransmitters Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) Sensory processing of sound by inner hair cells of the cochlea EPH-Ephrin signaling EPHA-mediated growth cone collapse EPH-ephrin mediated repulsion of cells Cation-coupled Chloride cotransporters RHO GTPases Activate Formins ERBB2 Regulates Cell Motility Neutrophil degranulation RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle RHOD GTPase cycle RHOF GTPase cycle Regulation of MITF-M dependent genes involved in invasion Synthesis of PIPs at the Golgi membrane HDACs deacetylate histones Regulation of PTEN gene transcription NGF-stimulated transcription Potential therapeutics for SARS Regulation of NPAS4 gene transcription Sensory processing of sound by outer hair cells of the cochlea Oligomerization of connexins into connexons Transport of connexins along the secretory pathway Gap junction assembly Transport of connexons to the plasma membrane Ub-specific processing proteases Formation of the beta-catenin:TCF transactivating complex HATs acetylate histones PIP3 activates AKT signaling Signaling by SCF-KIT Regulation of KIT signaling Constitutive Signaling by Aberrant PI3K in Cancer RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Transcriptional and post-translational regulation of MITF-M expression and activity Lysine catabolism SMAC (<span class="highlighting" >DIABLO</span>) binds to IAPs SMAC(<span class="highlighting" >DIABLO</span>)-mediated dissociation of IAP:caspase complexes Release of apoptotic factors from the mitochondria Apoptotic factor-mediated response Neurexins and neuroligins Synthesis of PC SLC-mediated bile acid transport Translocation of SLC2A4 (GLUT4) to the plasma membrane Regulation of actin dynamics for phagocytic cup formation Sema4D induced cell migration and growth-cone collapse RHO GTPases activate PKNs RHO GTPases activate CIT RHO GTPases Activate ROCKs RHO GTPases activate PAKs CD163 mediating an anti-inflammatory response FCGR3A-mediated phagocytosis Signaling by ALK fusions and activated point mutants Pyroptosis Regulation of TLR by endogenous ligand Defective pyroptosis XBP1(S) activates chaperone genes Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Post-translational modification: synthesis of GPI-anchored proteins Unwinding of DNA Switching of origins to a post-replicative state Assembly of the pre-replicative complex CDC6 association with the ORC:origin complex G1/S-Specific Transcription Integrin cell surface interactions Syndecan interactions ECM proteoglycans Gap junction degradation Formation of annular gap junctions EPHB-mediated forward signaling Adherens junctions interactions Recycling pathway of L1 VEGFA-VEGFR2 Pathway Interaction between L1 and Ankyrins Cell-extracellular matrix interactions RHO GTPases activate IQGAPs RHO GTPases Activate WASPs and WAVEs MAP2K and MAPK activation Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Clathrin-mediated endocytosis RHOBTB2 GTPase cycle Signaling downstream of RAS mutants Signaling by RAF1 mutants Regulation of CDH1 Function Formation of the dystrophin-glycoprotein complex (DGC) GBP-mediated host defense Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Collagen degradation Collagen biosynthesis and modifying enzymes Assembly of collagen fibrils and other multimeric structures Non-integrin membrane-ECM interactions MET activates PTK2 signaling Collagen chain trimerization Developmental Lineage of Pancreatic Ductal Cells Transcriptional activation of mitochondrial biogenesis Mitochondrial protein degradation Strand-asynchronous mitochondrial DNA replication Sphingolipid de novo biosynthesis Heme degradation Synthesis of Leukotrienes (LT) and Eoxins (EX) ABC-family proteins mediated transport Cytoprotection by HMOX1 Paracetamol ADME Transport of RCbl within the body NFE2L2 regulating MDR associated enzymes Signaling by Hippo Apoptotic cleavage of cell adhesion proteins The canonical retinoid cycle in rods (twilight vision) TBC/RABGAPs Voltage gated Potassium channels Positive Regulation of CDH1 Gene Transcription Trafficking of AMPA receptors RHOU GTPase cycle RHOBTB1 GTPase cycle B-WICH complex positively regulates rRNA expression Synthesis of bile acids and bile salts Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin Elevation of cytosolic Ca2+ levels Platelet homeostasis CDC42 GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle RHOQ GTPase cycle RHOG GTPase cycle RHOJ GTPase cycle RAC3 GTPase cycle Ion transport by P-type ATPases Formation of the ureteric bud Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion Deposition of new CENPA-containing nucleosomes at the centromere Mitotic Prometaphase EML4 and NUDC in mitotic spindle formation RSV-host interactions Cam-PDE 1 activation

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:90635(Orphanet)
  2. MONDO:0019587(MONDO)
  3. GARD:16791(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Q18553309(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA
Compêndio · Raras BR

Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA

ORPHA:90635 · MONDO:0019587
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
H90.3 · Perda de audição bilateral neuro-sensorial
CID-11
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4539881
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades